Zynamite® in Cognition and Mood in University Students

October 18, 2024 updated by: Agustín Aibar Almazán, University of Jaén

Effects of Zynamite® on Cognitive Function and Mood in University Students

This study examines the effects of a single dose of ZynS on cognitive function (memory, concentration, attention, and mental agility) in college students and will test the efficacy of this treatment on mood (anger, fatigue, vigor, agreeableness, tension, and depression).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Las Palmas De Gran Canaria, Spain
        • University of Atlántico Medio

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be an active undergraduate or graduate student
  • Be between 18 and 25 years of age
  • Be healthy and free of any relevant medical condition or disease.

Exclusion Criteria:

  • Suffer from chronic diseases such as asthma, type 1 diabetes, thyroid diseases (such as hypothyroidism or hyperthyroidism), autoimmune disorders (such as Crohn's disease) and psychiatric conditions such as anxiety disorders, major depression, eating disorders (anorexia, bulimia), attention deficit hyperactivity disorder (ADHD), among others; ii) Pregnancy or breastfeeding.
  • Known intolerance, hypersensitivity or allergies to any of the ingredients of the products under investigation;
  • Intestinal absorption problems, as well as learning difficulties, dyslexia, eye problems or color blindness;
  • Intake of psychoactive substances or medications that may influence the results of the study, such as consuming >500 mg of caffeine per day (>6 cups of 150 ml filtered coffee) and/or alcohol;
  • Having comprehension or communication difficulties that prevent full understanding of the informed consent or effective participation in the study, such as autism spectrum disorders, aphasia, or intellectual disability.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Placebo
Experimental: Zynamite® soluble 100mg
Two doses of Mangifera indica leaf extract in its soluble form, Zynamite® S, 100 mg of which 60 mg is mangiferin and 150 mg of which 90 mg is mangiferin, will be tested against a placebo. On the day of the test, the supplements will be administered 30 minutes before the start of the test. The supplements or placebo will be administered in cellulose capsules or similar and accompanied by a glass of water.
Experimental: Zynamite® soluble 150mg
Two doses of Mangifera indica leaf extract in its soluble form, Zynamite® S, 100 mg of which 60 mg is mangiferin and 150 mg of which 90 mg is mangiferin, will be tested against a placebo. On the day of the test, the supplements will be administered 30 minutes before the start of the test. The supplements or placebo will be administered in cellulose capsules or similar and accompanied by a glass of water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
del POMS (Profile Of Mood States)
Time Frame: Up to fourteen days
It has a total of 6 subscales: tension (score range, 0-36), depression (score range, 0-60), anger (score range, 0-48), fatigue (score range, 0-28), vigor (score range, 0-32), and confusion (score range, 0-28), and a total mood disturbance (score range, -32 to 200). Each of the questions will be scored from 0 (not at all) to 4 (very much so). The total mood disturbance score is calculated by summing the five negative subscale scores (tension, depression, anger, fatigue, and confusion) and subtracting the vigor score. Higher scores for the total mood disturbance score indicate a greater degree of mood disturbance.
Up to fourteen days
Rey Auditory Verbal Learning Test (RAVLT)
Time Frame: Up to fourteen days

The Rey Auditory Verbal Learning Test (RAVLT) is a neuropsychological test used to assess short- and long-term memory. The structure of the RAVLT consists of several parts:

  • Learning: Participants are read a list of 15 unrelated words (List A) in five consecutive trials.
  • Delayed Recall: The participant is asked to recall and repeat back the words from List A. To establish the score for this test, the following elements are considered to calculate the scores:

    • Total learning score: The total number of words correctly recalled in the five trials of List A is added up. Normal scores are 6 words correctly recalled in the first trial and 12 or 13 in the fifth trial. This reflects the ability for learning and short-term memory.
    • Delayed Recall: The number of words recalled from List A after the time interval without practice (20-30 minutes) is noted. This assesses long-term memory. The score can range from 0 to 15 points.
Up to fourteen days
Trail Making Test (TMT)
Time Frame: Up to fourteen days
It is used to assess executive function and specifically measures timed motor and visual tasks. This test is divided into two parts: Part A (TMT-A), which assesses psychomotor attention and speed and consists of connecting consecutively numbered circles; and Part B (TMT-B), which is based on connecting alternating circles of letters and numbers and measures executive function. A longer time spent completing the test is interpreted as worse performance.
Up to fourteen days
The Digit Symbol Substitution Test (DSST)
Time Frame: Up to fourteen days
Is a paper-and-pencil cognitive test presented on a single sheet of paper that requires the subject to match symbols to numbers according to a key located at the top of the page. The subject copies the symbol into spaces below a row of numbers. Scoring is based on the number of correct symbols the participant manages to substitute in 90 seconds of time.
Up to fourteen days
Stroop Color and Word Test
Time Frame: Up to fourteen days
It is used to assess selective attention. This test has a total of 3 slides, each lasting 45 seconds, with a total time of 5 minutes to complete the entire test. In order to read each slide correctly, it must be read from top to bottom and from left to right. The first slide (Stroop Word) is made up of 100 words in which the words "RED", "BLUE" and "GREEN" are repeated, ordered randomly and printed in black ink. This part assesses the number of words read in 45 seconds. After this time, participants must circle the last word they have read. The second slide (Stroop Color) is made up of 100 identical elements "XXXX" in blue, red and green ink. The participant must name the colour of "XXXX" as quickly as possible. Finally, the third slide (Stroop Word-Color) consists of 100 written words that refer to a colour, but are printed in a different colour. Participants must say the color of the ink each word is written in. Higher scores indicate better performance.
Up to fourteen days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2024

Primary Completion (Actual)

June 3, 2024

Study Completion (Actual)

June 10, 2024

Study Registration Dates

First Submitted

October 18, 2024

First Submitted That Met QC Criteria

October 18, 2024

First Posted (Actual)

October 22, 2024

Study Record Updates

Last Update Posted (Actual)

October 22, 2024

Last Update Submitted That Met QC Criteria

October 18, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • University (Other Identifier: Kahramanmaras Sutcu Imam University, SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on University Student

Clinical Trials on Zynamite

Subscribe